The addition of the mTORr inhibitor, Everolimus, to consolidation therapy in acute myeloid leukaemia: experience from the UK NCRI AML17 trial (Haematologica, 2018)

(untitled) - Burnett, AK; Gupta, ED; Knapper, S; Khwaja, A; Sweeney, M; Kjeldsen, L; Hawkins, T; Betteridge, SE; Cahalin, P; Clark, RE; Hills, RK; Russell, NH